SE8403179D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE8403179D0
SE8403179D0 SE8403179A SE8403179A SE8403179D0 SE 8403179 D0 SE8403179 D0 SE 8403179D0 SE 8403179 A SE8403179 A SE 8403179A SE 8403179 A SE8403179 A SE 8403179A SE 8403179 D0 SE8403179 D0 SE 8403179D0
Authority
SE
Sweden
Prior art keywords
sup
sub
carbon atoms
alkyl
hydrogen
Prior art date
Application number
SE8403179A
Other languages
English (en)
Swedish (sv)
Inventor
A E Brendstrom
P L Lindberg
B Wallmark
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20356221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8403179(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8403179A priority Critical patent/SE8403179D0/xx
Publication of SE8403179D0 publication Critical patent/SE8403179D0/xx
Priority to US06/739,425 priority patent/US4636499A/en
Priority to EP85850199A priority patent/EP0171372B1/fr
Priority to DE8585850199T priority patent/DE3565406D1/de
Priority to AT85850199T priority patent/ATE37719T1/de
Priority to JP60126398A priority patent/JPH0696581B2/ja
Priority to US06/913,689 priority patent/US4725691A/en
Priority to JP5268822A priority patent/JPH0739412B2/ja

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8403179A 1984-06-13 1984-06-13 New compounds SE8403179D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8403179A SE8403179D0 (sv) 1984-06-13 1984-06-13 New compounds
US06/739,425 US4636499A (en) 1984-06-13 1985-05-30 Sulphenamides
EP85850199A EP0171372B1 (fr) 1984-06-13 1985-06-06 Sulfénamides, procédés pour leur préparation et leur utilisation dans la préparation de compositions pharmaceutiques
DE8585850199T DE3565406D1 (en) 1984-06-13 1985-06-06 Sulphenamides, processes for their preparation and their use in the manufacture of pharmaceutical preparations
AT85850199T ATE37719T1 (de) 1984-06-13 1985-06-06 Sulphenamide, verfahren zur herstellung von diesen verbindungen und verwendung von obengenannten verbindungen zur herstellung von pharmazeutischen praeparaten.
JP60126398A JPH0696581B2 (ja) 1984-06-13 1985-06-12 新規なスルフエンアミド
US06/913,689 US4725691A (en) 1984-06-13 1986-09-30 2-[8-quinolinyl]-sulphinyl-1H-benzimidazole
JP5268822A JPH0739412B2 (ja) 1984-06-13 1993-10-27 新規なスルホキシド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8403179A SE8403179D0 (sv) 1984-06-13 1984-06-13 New compounds

Publications (1)

Publication Number Publication Date
SE8403179D0 true SE8403179D0 (sv) 1984-06-13

Family

ID=20356221

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403179A SE8403179D0 (sv) 1984-06-13 1984-06-13 New compounds

Country Status (6)

Country Link
US (2) US4636499A (fr)
EP (1) EP0171372B1 (fr)
JP (2) JPH0696581B2 (fr)
AT (1) ATE37719T1 (fr)
DE (1) DE3565406D1 (fr)
SE (1) SE8403179D0 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8505492D0 (en) * 1985-03-04 1985-04-03 Roussel Lab Ltd Chemical compounds
CA1276017C (fr) * 1986-02-13 1990-11-06 Takeda Chemical Industries, Ltd. Derives de sulfenamide, et leur production
EP0239129B1 (fr) * 1986-03-28 1991-09-25 Otsuka Pharmaceutical Co., Ltd. Composés hydroquinoléine, compositions les contenant et procédé pour leur préparation
AU604771B2 (en) * 1986-09-27 1991-01-03 Fisons Plc Pyridinylphenylthio and pyridinylphenylsulphinyl benzimidazone derivatives
WO1989010927A1 (fr) * 1988-05-12 1989-11-16 Eisai Co., Ltd. Sel de pyridinium et preparation pharmacologique le contenant
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
CA2444456A1 (fr) * 2001-04-09 2002-10-17 Teva Pharmaceutical Industries Ltd. Polymorphes de chlorhydrate de fexofenadine
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
WO2003104197A1 (fr) * 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Forme polymorphe xvi de l'hydrochlorure de fexofenadine
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
JP2006188432A (ja) * 2003-02-25 2006-07-20 Zeria Pharmaceut Co Ltd 四環系スルフェンアミド化合物
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (fr) * 2003-07-18 2016-01-19 Santarus, Inc. Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CA2561700A1 (fr) * 2004-04-16 2005-12-15 Santarus, Inc. Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
MXPA06012281A (es) * 2004-04-26 2007-07-18 Teva Pharma Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion.
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1685106A2 (fr) * 2004-09-28 2006-08-02 Teva Pharmaceutical Industries, Inc. Forme de cristal de fexofenadine et ses processus de preparation
WO2008067037A2 (fr) 2006-10-05 2008-06-05 Santarus, Inc. Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008047681A1 (fr) 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
EP2086543A2 (fr) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
JP2011512416A (ja) 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
JP6322644B2 (ja) 2012-11-26 2018-05-09 エムキュア ファーマシューティカルズ リミテッド 酸分泌阻害薬としてのピリドン誘導体およびその製造方法
WO2024075017A1 (fr) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition de calcification de valve aortique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation

Also Published As

Publication number Publication date
JPH06316573A (ja) 1994-11-15
EP0171372A1 (fr) 1986-02-12
US4636499A (en) 1987-01-13
JPH0696581B2 (ja) 1994-11-30
US4725691A (en) 1988-02-16
EP0171372B1 (fr) 1988-10-05
JPS617281A (ja) 1986-01-13
JPH0739412B2 (ja) 1995-05-01
DE3565406D1 (en) 1988-11-10
ATE37719T1 (de) 1988-10-15

Similar Documents

Publication Publication Date Title
SE8403179D0 (sv) New compounds
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
NO152130C (no) Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser
ES528157A0 (es) Un procedimiento para la preparacion de dihidropiridinas.
SE7709865L (sv) Nya fenyletylaminer och forfarande for framstellning derav
GB1430729A (en) Arylamino pyrimidinic derivatives their process ff preparation and their therapeutic application
ATE67193T1 (de) 6-phenyl-pyridazin-verbindungen.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
SE7709158L (sv) Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav
DE3070847D1 (en) Benzazepine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them
ES2058275T3 (es) Derivados biciclicos de sulfonamida y su preparacion, su uso y formulaciones que los contienen.
ATE22065T1 (de) Alkan- und alkenderivate und ihre herstellung und verwendung.
ATE43841T1 (de) 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
IT1193608B (it) Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.
ES8801202A1 (es) Un procedimiento para preparar derivados de alcanoles aroma-ticos heteropoliciclicos
GB2133012B (en) Quinazolines process for their preparation and pharmaceutical compositions containing them
SE7713779L (sv) Nya fenylderivat
FR2379505A1 (fr) Nouveaux produits doues notamment de proprietes therapeutiques, leurs procedes de preparation, et medicaments a base de ces produits
JPS5711970A (en) Quinazolinone compound and its preparation
Morton Jr et al. Inter-oxa-13, 14-dihydro-PGD 1 compounds
Peterson et al. 12, 13 (E)-Didehydro-13, 14-dihydro-PGD 2 compounds
ES477280A1 (es) Procedimiento para la obtencion de un diastereomero especi- fico de eritro-2-(2-aralquilamino-1-hidroxietil)-1,4-benzo- dioxanos.
GB1457256A (en) 1-phenoxy-2-formyloxy-3-2-cyanochromonyloxy-propanes